KalVista Pharmaceuticals, Inc.KALVNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-173.33M
↓ 160% below average
Average (9y)
$-66.55M
Historical baseline
Range
High:$-15.15M
Low:$-173.33M
CAGR
+31.1%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2025 | $-173.33M | -29.1% |
| 2024 | $-134.28M | -42.3% |
| 2023 | $-94.37M | -16.9% |
| 2022 | $-80.75M | -40.7% |
| 2021 | $-57.39M | -43.4% |
| 2020 | $-40.02M | -35.9% |
| 2019 | $-29.44M | -58.9% |
| 2018 | $-18.52M | +16.9% |
| 2017 | $-22.30M | -47.2% |
| 2016 | $-15.15M | - |